Evidence map›Paper›PMID 40536748›Full record

SynthesisEuropean geriatric medicine2025

Beneficial outcomes of medication review in patients with hip fractures: a systematic review.

Dina Aprillia Ariestine, Taro Kojima, Fakhriza Hidayati Siregar, Alvin Ivander

Abstract readSystematic Review
In one paragraph

Synthesis in European geriatric medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dina Aprillia AriestineDivision of Geriatric Medicine, Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. dina.aprillia@usu.ac.id.ORCID http://orcid.org/0000-0002-0522-0761
Taro KojimaDepartment of Geriatric Medicine, International University of Health and Welfare, Narita, Japan.ORCID http://orcid.org/0000-0003-3857-5267
Fakhriza Hidayati SiregarFaculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.ORCID http://orcid.org/0000-0001-7746-5509
Alvin IvanderFaculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.ORCID http://orcid.org/0000-0002-6263-5701

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aims to analyze medication review efficacy toward clinical outcomes in older adults with hip fractures.

methodsA systematic search was conducted using the modified keywords "medication review," "polypharmacy," and "hip fractures" to find relevant studies. Following the PRISMA guidelines, we reviewed published studies from 2014 to 2024. A total of 21 studies have been identified, six of which reported medication reviews for older adults with hip fractures.

resultsThe findings highlight the critical need for a multi-faceted strategy to address the challenges of polypharmacy in older adults with hip fractures. A higher number of medications is associated with some adverse outcomes, such as increased hospitalization rates, longer recovery times, and a greater incidence of pressure ulcers. Although minimizing inappropriate medications may show some positive results, focusing solely on medication management is insufficient in this vulnerable population.

conclusionMedication reviews have substantially mitigated medication-related issues, including costs, drug efficacy, and patient discomfort. Nevertheless, clinical outcomes have yet to exhibit significant improvement, which presents an opportunity for further research to explore the potential benefits of medication reviews in enhancing the care of patients with hip fractures. A holistic approach, which consists of medication review, patient education, and tailored rehabilitation programs, may be essential to improve recovery, decrease hospitalization rates, and prevent adverse events.

Indexed as

Hip FracturesPolypharmacyAgedHospitalizationHumansHip fracturesMedication reviewOlder adultsPolypharmacy

Identifiers

PMID40536748
PMCPMC12378730

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.